$40.43 0.09 (+0.22%)
2/10/2012 4:00 PM

Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Featured Broker Partners


Advertisement